Swiss National Bank’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.5M | Buy |
233,100
+2,700
| +1% | +$147K | 0.01% | 805 |
|
|
2025
Q4 | $10.6M | Buy |
230,400
+5,300
| +2% | +$237K | 0.01% | 943 |
|
|
2025
Q3 | $8.11M | Buy |
225,100
+3,800
| +2% | +$126K | ﹤0.01% | 1071 |
|
|
2025
Q2 | $7.19M | Buy |
221,300
+4,000
| +2% | +$131K | ﹤0.01% | 1087 |
|
|
2025
Q1 | $8.21M | Sell |
217,300
-1,700
| -0.8% | -$136K | 0.01% | 993 |
|
|
2024
Q4 | $17.9M | Buy |
219,000
+38,400
| +21% | +$3.81M | 0.01% | 679 |
|
|
2024
Q3 | $20.6M | Sell |
180,600
-700
| -0.4% | -$63.1K | 0.01% | 639 |
|
|
2024
Q2 | $13.7M | Buy |
181,300
+3,300
| +2% | +$225K | 0.01% | 749 |
|
|
2024
Q1 | $12.2M | Buy |
178,000
+30,100
| +20% | +$2.08M | 0.01% | 830 |
|
|
2023
Q4 | $9.29M | Sell |
147,900
-6,600
| -4% | -$343K | 0.01% | 921 |
|
|
2023
Q3 | $7.88M | Buy |
154,500
+5,500
| +4% | +$271K | 0.01% | 1010 |
|
|
2023
Q2 | $7.44M | Buy |
149,000
+29,700
| +25% | +$1.41M | 0.01% | 1066 |
|
|
2023
Q1 | $4.47M | Sell |
119,300
-6,400
| -5% | -$271K | ﹤0.01% | 1349 |
|
|
2022
Q4 | $6.03M | Buy |
125,700
+42,700
| +51% | +$1.68M | ﹤0.01% | 1202 |
|
|
2022
Q3 | $1.99M | Buy |
83,000
+3,400
| +4% | +$86.2K | ﹤0.01% | 1875 |
|
|
2022
Q2 | $1.73M | Buy |
79,600
+29,600
| +59% | +$685K | ﹤0.01% | 2022 |
|
|
2022
Q1 | $1.21M | Buy |
50,000
+4,100
| +9% | +$89.6K | ﹤0.01% | 2313 |
|
|
2021
Q4 | $1.09M | Buy |
45,900
+1,000
| +2% | +$23.3K | ﹤0.01% | 2431 |
|
|
2021
Q3 | $1.14M | Hold |
44,900
| – | – | ﹤0.01% | 2372 |
|
|
2021
Q2 | $1.01M | Buy |
44,900
+10,400
| +30% | +$213K | ﹤0.01% | 2477 |
|
|
2021
Q1 | $681K | Hold |
34,500
| – | – | ﹤0.01% | 2424 |
|
|
2020
Q4 | $917K | Buy |
+34,500
| New | +$1.28M | ﹤0.01% | 2336 |
|
Other funds holding PCVX
RCM
VPM
VCM
PBA
